Daiichi Sankyo Europe remote jobs and company guide

Daiichi Sankyo is a global pharmaceutical company with over 120 years of scientific expertise, headquartered in Tokyo and operating across more than 30 countries worldwide. In Europe, our company was founded in 2006 through the merger of Daiichi and Sankyo, establishing a strong presence with affiliates in 14 European countries and Canada. With approximately 2,500 employees in Europe and our European headquarters in Munich, we are one of the strongest Japanese pharmaceutical companies in the region.

Our European operations are anchored in two core therapeutic areas: cardiovascular disease and oncology. In cardiovascular care, our goal is to protect people from the leading cause of death in Europe, helping patients enjoy every precious moment of life. In oncology, we drive innovation in solid tumors and blood cancers, founded on breakthrough science from our own labs in Japan. We achieved global revenue of 1,886.3 billion JPY in FY2024, with 432.9 billion JPY invested in R&D to fuel our robust pipeline of innovative medicines that change standards of care.